A German external quality survey of diagnostic microbiology of respiratory tract infections in patients with cystic fibrosis.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
MetadataShow full item record
AbstractBACKGROUND: The goal of this pilot study was to design an external quality assessment (EQA) scheme for German cystic fibrosis (CF) clinical microbiology laboratories. Therefore, a multicentre study of 18 German CF laboratories was performed to evaluate their proficiency in analyzing CF respiratory secretions. METHODS: Simulated clinical specimens containing a set of four frequent CF pathogens, namely two Pseudomonas aeruginosa strains differing in morphotype (mucoid versus non-mucoid) and resistotype, one Staphylococcus aureus strain and one Burkholderia multivorans strain, were distributed to each laboratory. Isolation, identification and antimicrobial susceptibility testing (AST) of any bacterial pathogen present and completion of a questionnaire about applied microbiological protocols were requested. RESULTS: Three of four strains were isolated and identified correctly by almost all laboratories. B. multivorans was once misidentified as Burkholderia cenocepacia. Fourteen laboratories failed to detect the second multidrug resistant P. aeruginosa isolate. AST errors occurred most often for P. aeruginosa 2 followed by B. multivorans, P. aeruginosa 1 and S. aureus. Evaluation of the questionnaires revealed major differences in cultivation and identification techniques applied by the participating laboratories. CONCLUSIONS: A periodical EQA programme for German CF laboratories and standardized microbiological procedures seem to be necessary to advance diagnostic microbiology employed on CF respiratory tract specimens and may help to improve anti-infective treatment and infection control practices for CF patients.
CitationA German external quality survey of diagnostic microbiology of respiratory tract infections in patients with cystic fibrosis. 2008, 7 (1):7-14notJ Cyst Fibros
AffiliationInstitut für Medizinische Mikrobiologie und Krankenhaushygiene, Medizinische Hochschule Hannover, Carl-Neuberg-Strasse 1, 30625 Hanover, Germany.
- EuroCareCF quality assessment of diagnostic microbiology of cystic fibrosis isolates.
- Authors: Hogardt M, Ulrich J, Riehn-Kopp H, Tümmler B
- Issue date: 2009 Nov
- Isolation and identification of Burkholderia cepacia by participants in an external Quality Assurance Program (QAP) between 1994 and 1999.
- Authors: Taylor PC, McLaws ML, De Borde M, Pritchard R
- Issue date: 2004 Aug
- Bronchoalveolar lavage or oropharyngeal cultures to identify lower respiratory pathogens in infants with cystic fibrosis.
- Authors: Armstrong DS, Grimwood K, Carlin JB, Carzino R, Olinsky A, Phelan PD
- Issue date: 1996 May
- [Isolation frequency of Burkholderia cepacia from cystic fibrosis patients].
- Authors: Ocak F, Gözalan A, Ozçelik U, Anadol D, Kiper N, Aktepe OC, Göçmen A, Esen B
- Issue date: 2002 Jan
- Identification and antimicrobial susceptibility of Alcaligenes xylosoxidans isolated from patients with cystic fibrosis.
- Authors: Saiman L, Chen Y, Tabibi S, San Gabriel P, Zhou J, Liu Z, Lai L, Whittier S
- Issue date: 2001 Nov